Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GRM5 antisense RNA 1 (GRM5-AS1) is a long non-coding RNA transcribed antisense to the GRM5 gene, which encodes metabotropic glutamate receptor 5 (mGluR5). Antisense RNAs, like GRM5-AS1, regulate gene expression primarily by interacting with their sense (protein-coding) counterparts, potentially controlling transcription, modulating mRNA stability, or altering chromatin structure. Although antisense RNAs have important regulatory roles in many contexts, there is no direct evidence in current literature indicating that GRM5-AS1 has a specific, validated biological or disease-related function, nor is it a direct target for drugs or therapies. If your intention was to find information on mGluR5 (the protein-coding glutamate metabotropic receptor 5, encoded by the GRM5 gene), it is a well-studied therapeutic target in neurology and psychiatry. GRM5-AS1, however, is not a protein, receptor, or common therapeutic target, but a regulatory non-coding transcript. If you require information on the protein-coding GRM5 gene product (mGluR5), please specify.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on GRM5 antisense RNA 1 (GRM5-AS1).